Does Bisphenol A (BPA) Exposure Cause Human Diseases?

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2025 Jan 8

PMID 39767585

Authors

T Peter Stein

Affiliations

Soon will be listed here.

Abstract

Background: Autism spectrum disorders (ASDs), attention-deficit disorder (ADHD), Parkinson's disease (PD), polycystic ovary disease (PCOS), and Alzheimer's disease (AD) have all been linked to exposure to bisphenol A (BPA).

Methods: This paper is a review and discussion of the published literature.

Results: Animal studies have shown BPA to be a broad-spectrum endocrine disruptor. BPA is metabolized via the glucuronidation pathway, which involves the addition of glucose to the target molecule, and is catalyzed by uridine 5'-diphospho-glucuronosyltransferases (UGTs). Evidence of compromised glucuronidation has been found for ASD, DHD, PD, and PCOS. Genetic polymorphisms that alter the catalytic activity of the UGTs and efflux transporters involved are common. There are two ways to interpret the findings of associations between BPA glucuronidation efficiency and disease, a 'direct' pathway and an 'indirect' pathway. With the 'direct' pathway, free BPA is the actual causative agent. Compromised BPA detoxification leads to higher concentrations of free BPA in vulnerable tissues. Decreased BPA detoxification leads to increased exposure of vulnerable tissues to free BPA, where it can function as an endocrine disruptor. With the 'indirect' pathway, BPA is not the causative agent. BPA serves as a marker for the decreased glucuronidation efficiency of another unknown compound of endogenous origin detoxified by a similar combination of UGTs and efflux transporters as BPA. It is this compound(s), acting as an endocrine disruptor, that leads to a metabolic environment that favors disease development over an extended time period.

Conclusion: A review of the existing literature supports the indirect 'marker' hypothesis over the 'direct' hypothesis.

References

Bleuze L, Triaca V, Borreca A . FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game. Front Mol Biosci. 2021; 8:699613. PMC: 8573832. DOI: 10.3389/fmolb.2021.699613. View

Tastet V, Le Vee M, Bruyere A, Fardel O . Interactions of human drug transporters with chemical additives present in plastics: Potential consequences for toxicokinetics and health. Environ Pollut. 2023; 331(Pt 2):121882. DOI: 10.1016/j.envpol.2023.121882. View

Minatoya M, Kishi R . A Review of Recent Studies on Bisphenol A and Phthalate Exposures and Child Neurodevelopment. Int J Environ Res Public Health. 2021; 18(7). PMC: 8036555. DOI: 10.3390/ijerph18073585. View

Bourque M, Morissette M, Di Paolo T . Neuroactive steroids and Parkinson's disease: Review of human and animal studies. Neurosci Biobehav Rev. 2023; 156:105479. DOI: 10.1016/j.neubiorev.2023.105479. View

Masuo Y, Ishido M . Neurotoxicity of endocrine disruptors: possible involvement in brain development and neurodegeneration. J Toxicol Environ Health B Crit Rev. 2011; 14(5-7):346-69. DOI: 10.1080/10937404.2011.578557. View

Bock K . Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors. Biochem Pharmacol. 2012; 84(8):1000-6. DOI: 10.1016/j.bcp.2012.07.009. View

Thayer K, Doerge D, Hunt D, Schurman S, Twaddle N, Churchwell M . Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ Int. 2015; 83:107-15. PMC: 4545316. DOI: 10.1016/j.envint.2015.06.008. View

Dumesic D, Oberfield S, Stener-Victorin E, Marshall J, Laven J, Legro R . Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015; 36(5):487-525. PMC: 4591526. DOI: 10.1210/er.2015-1018. View

Ishihara K, Takata K, Mizutani K . Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases. Life (Basel). 2023; 13(1). PMC: 9866034. DOI: 10.3390/life13010221. View

10.

Santos J, Rasga C, Marques A, Martiniano H, Asif M, Vilela J . A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics. Front Neurosci. 2022; 16:862315. PMC: 9161282. DOI: 10.3389/fnins.2022.862315. View

11.

Shao Y, Li T, Liu Z, Wang X, Xu X, Li S . Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry. Mol Neurodegener. 2021; 16(1):4. PMC: 7825156. DOI: 10.1186/s13024-021-00425-8. View

12.

Mir R, Sawhney G, Pottoo F, Mohi-Ud-Din R, Madishetti S, Jachak S . Role of environmental pollutants in Alzheimer's disease: a review. Environ Sci Pollut Res Int. 2020; 27(36):44724-44742. DOI: 10.1007/s11356-020-09964-x. View

13.

Vahedi M, Saeedi A, Poorbaghi S, Sepehrimanesh M, Fattahi M . Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome. Environ Sci Pollut Res Int. 2016; 23(23):23546-23550. DOI: 10.1007/s11356-016-7573-5. View

14.

Volkel W, Colnot T, Csanady G, Filser J, Dekant W . Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol. 2002; 15(10):1281-7. DOI: 10.1021/tx025548t. View

15.

Berni T, Morgan C, Aled Rees D . Rising incidence, health resource utilization and costs of Polycystic Ovary Syndrome in the United Kingdom. J Clin Endocrinol Metab. 2024; . DOI: 10.1210/clinem/dgae518. View

16.

Scaramella C, Alzagatiti J, Creighton C, Mankatala S, Licea F, Winter G . Bisphenol A Exposure Induces Sensory Processing Deficits in Larval Zebrafish during Neurodevelopment. eNeuro. 2022; 9(3). PMC: 9116930. DOI: 10.1523/ENEURO.0020-22.2022. View

17.

Hahladakis J, Velis C, Weber R, Iacovidou E, Purnell P . An overview of chemical additives present in plastics: Migration, release, fate and environmental impact during their use, disposal and recycling. J Hazard Mater. 2017; 344:179-199. DOI: 10.1016/j.jhazmat.2017.10.014. View

18.

Mackenzie P, Bock K, Burchell B, Guillemette C, Ikushiro S, Iyanagi T . Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics. 2005; 15(10):677-85. DOI: 10.1097/01.fpc.0000173483.13689.56. View

19.

Cimmino I, Fiory F, Perruolo G, Miele C, Beguinot F, Formisano P . Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease. Int J Mol Sci. 2020; 21(16). PMC: 7460848. DOI: 10.3390/ijms21165761. View

20.

Zeng J, Kuang H, Hu C, Shi X, Yan M, Xu L . Effect of bisphenol A on rat metabolic profiling studied by using capillary electrophoresis time-of-flight mass spectrometry. Environ Sci Technol. 2013; 47(13):7457-65. DOI: 10.1021/es400490f. View